Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

Z
Za T. - Risk for recurrent venous thromboembolism after a first superficial vein thrombosis among carriers of inherited thrombophilia
  - Inherited thrombophilia and associated risk for unexplained fetal loss
  - Risk for venous thromboembolism among younger or older carriers of inherited thrombophilia
  - Risk for venous thrombosis in unusual sites associated with inherited thrombophilia: analysis of 133 patients
Zabe M. - Translocation of plasma membrane Ca2+-ATPase to filopodia during platelet activation
Zacharof A. - Anti-phospholipid syndrome in systemic lupus erythematosus
Zacharof H. - Anti-phospholipid syndrome in systemic lupus erythematosus
Zacharof L. - Anti-phospholipid syndrome in systemic lupus erythematosus
Zacharski L. R. - P-selectin-dependent lung colonization of melanoma cells is targeted by heparin treatment
Zacharski L. R. - Correlation of the serum ferritin (SF) levels with cholesterol and body mass index (BMI) in patients with advanced atherosclerosis
Zacharski L. R. - Reducing body iron stores lowers inflammatory cytokine levels in atherosclerotic claudicants
Zadro R. - Comparative evaluation of four rapid quantitative D-dimer assays
Zadro R. - The combination of lupus anticoagulant sensitive and insensitive aPTT reagent together with dRVVT screening reagent for the exclusion of the presence of lupus anticoagulant
Zago M. A. - Factor XIII (FXIII) Val34Leu, His95Arg and G30899A polymorphisms and the risk of deep venous thrombosis
  - A 23-bp insertion in the EPCR gene and the risk of venous thrombosis
  - A functional single-nucleotide polymorphism in the thrombin-activatable fibrinolysis inhibitor (TAFI) associated with risk and outcome of meningococcal disease (MD)
  - A transcobalamin gene polymorphism and the risk of deep venous thrombosis
Zaharaki A. - Obesity and coagulation. Is there any correlation?
  - Correlation SVCAM, SICAM plasma levels with the outcome of treadmill test and with attitudinal factors for coronary artery disease in patients without previous history of ischemic heart disease
  - Smoking and abnormalities of coagulation-fibrinolysis in patients with coronary heart disease
  - Is there an hypercoagulable state after treadmill exercise in patients with atrial fibrillation?
  - Levels of plasma tissue activator plasminogen (tPA)- A useful marker in the differential diagnosis of chest pain (marker of plaque destabilization)
  - Inflammatory factors in patients with acute coronary syndromes. Is there any fluctuation with smoking or cholesterol levels?
  - Correlation between SVCAM, SICAM plasma levels, the outcome of treadmill test and the systolic function of left ventricular (LV) in patients with coronary artery disease
Zahler S. - Magnetofection – a highly efficient tool for endothelial gene transfer and antisense oligonucleotide delivery in vitro and in vivo
Zahrani H. - Single center review of clinicopathological characterization in 77 patients with positive lupus anticoagulant antibodies
Zaid D. - The mannometric profile of native arteriovenous fistulas in the Avicenne Hemodialysis Center of Casablanca (preliminary results)
Zalavras C. - Mutations of the methylenetetrahydrofolate reductase (MTHFR) gene and osteonecrosis. A preliminary report
Zalavras C. - Is the G455A polymorphism of the fibrinogen beta gene associated with osteonecrosis? A preliminary report
Zalepouchina O. - Red blood cells ABH and Lewis antigens prevalence in von Willebrand disease patients
Zamagni E. - Venous thromboembolic complications in patients with multiple myeloma treated with thalidomide:prophylatic effect of fixed dose Wafarin L
Zamboni P. - The G>T point mutation (Val34Leu) in the Factor XIII-A subunit gene in venous leg ulcers
Zamd M. - The mannometric profile of native arteriovenous fistulas in the Avicenne Hemodialysis Center of Casablanca (preliminary results)
Zamora-Gonzalez J. - Lipoprotein (a) polymorphisms in Mexican-Amerindian populations
Zampolli A. - Statins inhibit cyclo-oxygenase (cox)-2 and metalloproteinase (mmp)-9 expression in human endothelial cells: possible contribution to plaque stability
Zanardo G. - Contemporary total hip and knee replacement in A patients with haemophilia and high titre of inhibitors to FVIII by using recombinant FVIIa (novoseven) continuous infusion
  - Management of oral anticoagulant therapy in the perioperative period: preliminary results of the application of an operative protocol
Zanazzi M. - Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal transplant recipients
Zander A. R. - Use of recombinant factor VIIa in severe acquired coagulopathies in childhood
Zandstra D. F. - Lepirudin anti-coagulation in critically ill patients with (suspected) heparin-induced thrombocytopenia and thrombosis
Zanna D. - Increased procoagulant activity and impaired fibrinolytic potential in blood mononuclear cells after coronary angioplasty for stable or unstable angina
Zanon E. - Factor VII deficiency associated with severe hemophilia A
Zanon E. - Anti-prothrombin antibodies in patients with recurrent venous thromboembolism
Zarzur J. - Development, scale up and characterization of the first regional high purity Factor VIII: the Argentinean experience
Zarzur J. A. - Preparation of prothrombin complex concentrate (PCC) at intermediate scale: first experience in Argentina
Zavalova L. L. - Anti-hemostasis stimulated by the medicinal leech application as a result of mast cells activation by the leech saliva
Zavalova L. - Proposed mechanisms of thrombolytic action of the medicinal leech saliva
Zawadsky C. - Three abnormal patterns for inversion breaking intron 1 of the FVIII gene
Zawadzki C. - Tissue factor predicts long-term outcome after percutaneous coronary revascularization
  - Tissue factor pathway in carotid atherosclerotic plaques: relationships with clinical patterns and risk factors
  - Effect of in vivo thrombin inhibition on bFGF-induced angiogenesis in a murine angiogenic model
Zawilska K. - High frequency of combined genetic prothrombotic defects in young patients with ischemic stroke
  - The influence of Percutaneous Transluminal Coronary Angioplasty (PCTA) in patients with stable angina on the inflammation markers, lymphocyte activation and platelet-leukocyte aggregates in peripheral venous blood
  - Thrombin activable fibrinolysis inhibitior (TAFI) in patients with obesity
  - Antiphospholipid antibodies in patients diagnosed for thrombophilia
Zdziarek J. - Fibrinolytic activity of venous endothelium in postphlebitic syndrome
Zehnder J. L. - Intrauterine growth retardation and recurrent pregnancy loss associated with prothrombin gene variants 20221C > T and 20209C > T
  - Novel factor V mutations in three separate families resulting in factor V deficiency and bleeding
Zeinali S. - Prenatal diagnosis of dysprothrombinemia in an Iranian family
  - Reporting presence of 9 novel mutations in hemophilia B patients in Iran
  - Psychosocial aspects of inherited bleeding disorders among Iranian patients
  - Rapid analysis of the HindIII/intron 19 polymorphism within the human factor VIII gene by ARMS/PCR method
  - Rapid screening of factor IX mutations by SSCP and sequencing in 50 Iranian families
Zeinali S. - Prenatal diagnosis of hemophilia A in the only governmental center for prenatal diagnosis in IRAN
Zeinali M. - Prenatal diagnosis of hemophilia A in the only governmental center for prenatal diagnosis in IRAN
Zeiner A. - High prevalence of aspirin resistance in patients with acute coronary syndromes
Zelcer S. - Thrombosis in patients with immune thrombocytopenic purpura (ITP): a case series
Zenz W. - Variation in plasminogen activator inhibitor-1 gene and risk of meningococcal disease
Zeratti E. A. - Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis
Zerbinati P. - Correlation between internal carotid artery stenosis and hematological risk factors for thrombosis (CAST study): final results
  - Levels of anti-thrombin III activity in the plasma of cynomolgus monkeys after administration of recombinant human anti-thrombin III
  - Anti-thrombin III levels in cynomolgus monkey recipients of a life-supporting porcine renal xenograft
  - The incidence of venous thromboembolism in double-heterozygous carriers of antithrombin, protein C and protein S deficiency and HR2 haplotype
  - The incidence of venous thromboembolism in homozygous or double heterozygous carriers of the factor V Leiden mutation, prothrombin 20210 A mutation and HR2 aplotype: interim report
  - The incidence of venous thromboembolism in carriers of single identified prothrombin G20210A: a retrospective cohort study
  - Incidence of recurrent ischemic stroke in children with coagulation abnormalities
Zervas K. - Effect of rFVIIa (NovSeven®) on thrombin generation in patients with severe thrombocytopenia
Zewald R. A. - The relation between clinical phenotype and genotype of severe hemophilia A
Zhai W. - Soluble platelet GPV: a new marker of thrombosis status
Zhai Z. - Increased fibronectin secretion but not cell surface expression in thrombin-activated platelets of hypofibrinogenemia patients
Zhang C. - Transgenic mice studies demonstrate a role for platelet factor 4 (PF4) in thrombosis: implications for heparin-induced thrombocytopenia (HIT)
Zhang B. - MCFD2, a second gene defective in combined factor V/factor VIII deficiency, encodes a novel ER protein that interacts with LMAN1 (ERGIC-53) to form a cofactor-specific sorting receptor
Zhang W. - A novel point mutation in the transmembrane domain of the platelet glycoprotein IX associated with bernard–soulier syndrome
Zhang W. - Thrombin activates the cGMP-inhibited cAMP-dependent phosphodiesterase (PDE3A) in platelets
Zhang K. - Mechanisms of homeostasis of blood coagulation factors
Zhang C. - Murine (m) aIIb out-competes human (h) aIIb for mouse b3 in a transgenic mouse model: Implications for integrin subunit interactions
  - Evaluation of IgG formation to trace mammalian proteins in hemophilia patients treated with a recombinant therapeutic protein preparation
Zhao J. - Limited exposure of phosphatidylserine on stimulated platelets is necessary for procoagulant activity and provides binding sites for lactadherin
Zhao L. - Platelet–leukocyte interactions in the presence of GPIIb-IIIa antagonists, and a combination of aspirin, dipyridamole and AR-C69931
Zhao B.-Q. - Increased expression of endogenous tissue-type plasminogen activator and matrix metalloproteinase 9 contribute to heparin-produced cerebral hemorrhage after focal cerebral ischemia in mice
Zhao L. - The effects of three anti-platelet drugs (aspirin, clopidogrel, dipyridamole) given singly or together on platelet and leukocyte function in healthy subjects and patients with previous ischemic stroke
Zhao Z. - Development of small molecule compounds that inhibit PAI-1 activity in vitro and in vivo
Zhao X. - A novel point mutation in the transmembrane domain of the platelet glycoprotein IX associated with bernard–soulier syndrome
Zhao L. - Activated platelets and platelet-derived microvesicles (PMV) transfer tissue factor (TF) to monocytes but not to neutrophils
Zharkova T. - Efficacy of 1-year acenocumarol therapy and its relation with gene polymorphism related to thrombophilia in patients with nonvalvular atrial fibrillation
Zhauchao Y. - Simultaneous occurrence of lupus anticoagulant and factor VIII inhibitors in hyperththyroisis
Zheng H. - Combined carrier status of prothrombin 20210 A and factor XIII-A L34 alleles as a strong risk factor for myocardial infarction: evidence of a gene–gene interaction
Zheng S. - Multimerin supports platelet adhesion by functioning as an RGD ligand for platelet integrin receptors
Zhimin Z. - The clinical significance of TpP in patient with acute coronary syndrome
Zhong D. - Characterization of a monoclonal antibody to factor VIII: epitope mapping and mechanism of inhibition
Zhou H. - The epidemiology of venous thromboembolism in California
Zhou Q. - Evidence that interaction of the A2 domain of factor VIIIa with factor IXa occurs over an extended surface
  - Copper binding site(s) in factor VIII involved in the regulation of cofactor specific activity
Zhou L. - Preparation of special proteome chip and the application in primary screening of antigens of clotting factors of clinical plasma specimens
Zhou H. - Inhibition of anti-phospholipid antibody-induced monocyte tissue factor activity by dipyridamole and dilazep: role of adenosine
Zhou A. - Measurement of the in-vitro half life and the pathological significance of the transition of anti-thrombin to the latent state
Zhou H. - Cell surface annexin A2 (ANX2) mediates the up-regulation of monocyte tissue factor activity by b2-glycoprotein I (b2GPI) and anti-b2GPI autoantibodies
  - Effect of age on the incidence of venous thromboembolism after surgery
Zhou A. - How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration
Zhu H. - A recombinant von Willebrand factor fragment inhibits binding of von Willebrand factor to glycoprotein Ib-IX
Zhu H. - Dominant negative anticoagulant effects of mouse recombinant meizothrombin precursor R157A/R268A delay thrombus formation in a mouse injured carotid artery
  - A transgenic mouse model demonstrates the efficacy of Factor VIII ectopically expressed in platelets for Haemophilia A treatment
Zhu X. Y. - A chimeric anti-human tissue factor antibody attenuates inflammatory responses in rhesus monkeys challenged with E. coli
Ziakas G. - Congenital defect of inferior vena cava and thrombophilia Leiden
Zibara K. - Structural and functional characterization of a new transcription factor (6A3-5) potentially implicated in changes of smooth muscle cells phenotype
Zibis A. H. - Is the G455A polymorphism of the fibrinogen beta gene associated with osteonecrosis? A preliminary report
  - Mutations of the methylenetetrahydrofolate reductase (MTHFR) gene and osteonecrosis. A preliminary report
Zidane M. - A prospective implementation study of out-patient treatment with subcutaneous low-molecular-weight heparin and oral anti-coagulants in patients with deep venous thrombosis in routine clinical practice
Zieger B. - Insufficient F IX-recovery after treatment with recombinant F IX compared to plasma-derived F IX
Zieger B. - Sinus venous thrombosis in children – a multifactorial etiology
Ziegler H. - A rapid chromogenic method for determination of TAFI in plasma samples
Zieleniewska B. - Immune tolerance induction in the treatment of children with haemophilia A complicated by factor VIII inhibitor
Zielinski J. - Compression ultrasound in diagnosis of asymptomatic deep venous thrombosis
Ziemer S. - Recombinant PrPP102L stimulates t-PA mediated plasminogen activation 4-fold stronger than recombinant wild-type PrPc
Zieseniss S. - Microvesicle and platelet associated tissue factor promote initiation of coagulation
Zighetti M. L. - Does plasma homocysteine influence the in vitro anti-coagulant response to activated Protein C?
  - Inherited thrombophilia and hyperhomocysteinemia in upper limb deep vein thrombosis
Zimmerman T. - In vitro assessment of inhibitory potential of plasma and whole blood toward exogenous plasmin
Zimmermann R. - The development of inhibitors directed against factor VIII after continuous infusion of factor VIII concentrates in patients with hemophilia A
Zimmermann M. - Platelet receptor polymorphism HPA-1b and the G20210A mutation of the prothrombin-gene are risk determinants of vascular access thrombosis in hemodialysis patients
Zimmermann K. - Surface exposed mutation W2313A in the C2-domain of FVIII results in defective secretion of otherwise functional protein
  - Towards the development of a recombinant von Willebrand factor-cleaving protease (ADAMTS-13)
  - ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS-13
Zingale G. - Preparation of prothrombin complex concentrate (PCC) at intermediate scale: first experience in Argentina
  - Development, scale up and characterization of the first regional high purity Factor VIII: the Argentinean experience
Zivelin A. - Substitutions of conserved Gly193 (numbering according to chymotrypsin) located near the catalytic triad of factors VII, IX and XI yield dysfunctional proteins probably due to interference with accessibility of the respective substrates
Zivelin A. - Aging of ancestral mutations causing factor VII deficiency and Dubin–Johnson syndrome in Iranian and Moroccan Jews reflects ancient Jewish migrations
Zivelin A. - Cys61stop is the first identified nonsense mutation in the factor X gene causing severe factor X deficiency in 3 unrelated homozygotes of Arab origin
Zivelin A. - The severely impaired thrombin generation in 5 patients with severe factor XI deficiency and inhibitors is corrected in vitro by recombinant factor VIIa
Zivkovic M. - Comparative evaluation of four rapid quantitative D-dimer assays
Zlokovic B. V. - Recombinant murine activated protein C is neuroprotective in a murine ischemic stroke model
  - In vivo activated protein C (APC) neuroprotective activity involves endothelial protein C receptor (EPCR) and protease activated receptor 1 (PAR-1)
  - Protein S confers neuronal protection during ischemic/hypoxic injury in mice
  - Activated protein C (APC) blocks p53-mediated apoptosis in ischemic human brain endothelium through endothelial protein C receptor (EPCR) and protease activated receptor 1 (PAR-1)
Zogg M. - Platelets and fibrinogen are not required for embryonic development but have distinct roles for placentation
  - Altered vascular remodeling in hyperfibrinogenemic mice
Zoghlami-Rintelen C. - Is inflammation involved in the development of thrombosis in patients with the lupus anticoagulant?
Zoghlami-Rintelen C. - IgG-antibodies (IgG-Ab) against beta-2-glycoprotein I (b2-GPI) are associated with an increased risk for thrombotic events (TE) in patients (pts) with the lupus anticoagulant (LA)
Zografidis T. - Population pharmacokinetics of the ReFacto coagulation factor VIII in clinical hemophilia patients with HIV
Zoller N. - Triglycerides show an immediate increase during anticoagulant therapy for DVT without increase in thrombin generation
Zollman A. - Examining the role of coagulation Factor VII using FVII-insufficient mice
Zollner T. M. - P-selectin-dependent lung colonization of melanoma cells is targeted by heparin treatment
Zolotarova E. - Both shear and temperature can profoundly alter antithrombotic drug efficacy: demonstration with the P2Y12 ADP receptor antagonist, ARC-69931MX
Zomas A. - Early therapeutic splenectomy may reduce morbidity and management costs in selected resistant or relapsing cases of TTP/HUS
Zonzin P. - Long-term clinical outcome of patients with pulmonary embolism: a prospective, multicenter study
  - Incidence of newly diagnosed cancer after three months or one year of oral anticoagulation for a first episode of idiopathic venous thromboembolism
Zorio E. - Lipoprotein (a) levels and isoforms and fibrinolytic parameters in young survivors of myocardial infarction with and without peripheral artery disease
Zotz R. B. - High levels of plasma markers of coagulation factors (I, VIII:C, XI, XII), inflammation, and hyperhomocysteinemia are risk determinants of pre-eclampsia and HELLP syndrome
Zotz R. - A multinational observational cohort study in hospitalized medical patients of practices in prevention of venous thromboembolism and clinical outcomes: findings of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)
Zotz R. B. - High levels of plasma markers of coagulation factor VIII:C and von Willebrand factor are independent risk determinants of pregnancy-associated venous thromboembolism
Zotz R. B. - Platelet receptor polymorphisms of glycoprotein (GP) Iba VNTR, GP IIb-IIIa (HPA–1), and GP Ia C807T and the risk of premature myocardial infarction
Zotz R. B. - Influence of anti-thrombin on platelet adhesion onto immobilized fibrinogen in simulated low flow in vitro system
Zotz R. - Lipid levels and homocysteine are determinants which influence the epinephrine–collagen- and ADP–collagen-closure time
  - Platelet receptor polymorphism HPA-1b and the G20210A mutation of the prothrombin-gene are risk determinants of vascular access thrombosis in hemodialysis patients
Zotz R. B. - Rapid induction of immune tolerance with von Willebrand factor containing factor VIII concentrate in acquired hemophilia A
Zouaoui Boudjeltia K. - A new Global Plasma Fibrinolytic Assay for the rapid analysis of hyper-/hypo-Fibrinolysis: relationship with blood lipids and inflammatory markers
  - The biphasic waveform of APTT optical clot formation profile is related with the activation of FVII but not with ISTH DIC score or classical coagulation activation parameters
Zovko V. - Comparative evaluation of four rapid quantitative D-dimer assays
Zozulinska M. - Antiphospholipid antibodies in patients diagnosed for thrombophilia
Zuber M. - Genetic polymorphisms and the risk of development of ischemic stroke. Result of a case control study
Zubizarreta A. - Successful use of recombinant FVIIa (Novoseven) for severe bleeding in a patient undergoing bone marrow transplantation refractory to standard hemostatic support
  - Recombinant Factor VIIa as hemostatic agent in acquired von Willebrand disease
Zucker M. - A novel recombinant tissue factor assay for measuring the anti-Xa effect of Low-Molecular-Weight Heparin (LMWH): implications for interventional coronary procedures
Zucker M. L. - Safety of low intensity warfarin regimen in Chinese patients With mechanical heart valve prostheses
Zucker M. - Precision of INR (International Normalized Ratio) measurement using laboratory and point-of-care assays: Understanding the impact of system influence on patient management
Zuckerman L. A. - Agreement between FXIII activity assays and calibrator plasma pools: the need for a FXIII reference standard with regulatory recognition
Zuckerman L. A. - Pharmacokinetics of recombinant human FXIII in cynomolgus monkeys
Zuckerman L.A. - A randomized, double-blind, placebo-controlled study of the safety and pharmacokinetics of a single dose of recombinant Factor XIII in healthy volunteers
Zufferey P. - A meta-analysis on the benefit-to-risk ratio of Vitamin K antagonists (VKA) in the prevention of venous thromboembolism in major orthopedic surgery
Zuo Y. - Inflammatory modulation of alveolar coagulation inhibition in a mouse model of acute respiratory distress syndrome (ARDS)
Zurlini C. - An alternative model for management of oral anticoagulant therapy: role of general practitioners with support of a computerized system and a portable coagulometer
Zuurveld M. G. - A mouse model for inhibitor development in mild hemophilia A
Zwaal R. F. A. - IgG antiprothrombin antibodies from patients with antiphospholipid syndrome inhibit the inactivation of Factor Va by activated protein C
Zwaginga J. J. - a4 integrins and P-selectin mediate rolling and initial attachment of platelet-monocyte complexes to activated endothelium under flow conditions
Zwart J. E. F. - An evaluation of 30 years of hemophilia treatment in the Netherlands
Zweegman S. - Venous thrombosis and APC resistance during hormone treatment in male-to-female transsexuals
Zwerts F. - Endothelial-specific inactivation of survivin in mice results in embryonic lethality with intraembryonic bleeding due to loss of vascular endothelial integrity
Zwinge B. - Important Role of FV G1691A and FII G20210A in women with pregnancy loss without apparent causes
  - Association between factor XIII Val34Leu polymorphism and risk of ischemic stroke in young patients